Label: ASPERCREME LIDOCAINE WITH EUCALYPTUS ESSENTIAL OIL- lidocaine hcl cream

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated October 24, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Aspercreme Lidocaine with Eucalyptus Essential Oil

    Drug Facts

  • Active ingredient

    Lidocaine HCl 4%

  • Purpose

    Topical anesthetic

  • Use

    for the temporary relief of pain

  • Warnings

    For external use only

    Flammable: keep away from fire or flame.

    Do not use 

    ■ in large quantities 

    ■ on wounds or on irritated or damaged skin

    ■ with a heating pad

    When using this product

    ■ use only as directed

    ■ do not bandage tightly

    ■ avoid contact with eyes and mucous membranes

    ■ do not expose the area to local heat or to direct sunlight

    Stop use and ask a doctor if

    ■ condition worsens or symptoms persist for more than 7 days

    ■ symptoms clear up and occur again within a few days

    ■ redness is present or excessive skin irritation occurs

    ■ you experience severe burning pain, swelling, or blistering where the product was applied

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    ■ adults and children 12 years of age and older:

          ■ apply a thin layer to affected area every 6 to 8 hours, not more than 3 to 4 times daily

          ■ massage until thoroughly absorbed into skin

          ■ wash hands thoroughly with soap and water after each use

    ■ children under 12 years of age: ask a doctor

  • Inactive ingredients

    alcohol denat. (15%), aloe barbadensis leaf juice, C15-19 alkane, caprylic/capric triglyceride, carbomer, cetearyl alcohol, citric acid, ethylhexylglycerin, eucalyptus globulus leaf oil, glycerin, glyceryl stearate, hydroxyacetophenone, potassium hydroxide, polysorbate 60, propanediol, steareth-2, steareth-21, water

                                                                                     373-005

    Child-resistant packaging. Close cap tightly after use.

    Keep carton as it contains important information.

  • PRINCIPAL DISPLAY PANEL

    Aspercreme
    Lidocaine with Eucalyptus Essential Oil
    Numbs away pain
    NET WT 3 oz (85 g)

    PRINCIPAL DISPLAY PANEL Aspercreme Lidocaine with Eucalyptus Essential Oil Numbs away pain NET WT 3 oz (85 g)

  • INGREDIENTS AND APPEARANCE
    ASPERCREME LIDOCAINE WITH EUCALYPTUS ESSENTIAL OIL 
    lidocaine hcl cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:41167-0566
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) LIDOCAINE HYDROCHLORIDE ANHYDROUS4 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    C15-19 ALKANE (UNII: CI87N1IM01)  
    MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
    CARBOXYPOLYMETHYLENE (UNII: 0A5MM307FC)  
    CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    EUCALYPTUS OIL (UNII: 2R04ONI662)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
    HYDROXYACETOPHENONE (UNII: G1L3HT4CMH)  
    POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  
    POLYSORBATE 60 (UNII: CAL22UVI4M)  
    PROPANEDIOL (UNII: 5965N8W85T)  
    STEARETH-2 (UNII: V56DFE46J5)  
    STEARETH-21 (UNII: 53J3F32P58)  
    WATER (UNII: 059QF0KO0R)  
    ALCOHOL (UNII: 3K9958V90M)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:41167-0566-01 in 1 CARTON01/15/2023
    185 g in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01701/15/2023
    Labeler - Chattem, Inc. (003336013)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!